第一单位：
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. emily_rencsok@hms.harvard.edu.
作者：
Emily M,Rencsok [1]
;
Latifa A,Bazzi [2]
;
Rana R,McKay [3]
;
Franklin W,Huang [4]
;
Adam,Friedant [5]
;
Jake,Vinson [6]
;
Samuel,Peisch [6]
;
Jelani C,Zarif [7]
;
Stacey,Simmons [8]
;
Kelly,Hawthorne [9]
;
Paul,Villanti [10]
;
Philip W,Kantoff [10]
;
Elisabeth,Heath [11]
;
Daniel J,George [12]
;
Lorelei A,Mucci [13]
作者单位：
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. emily_rencsok@hms.harvard.edu.
[1]
Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts.
[2]
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
[3]
Department of Oncology, University of California San Diego Moores Cancer Center, La Jolla, California.
[4]
Department of Hematology and Oncology, University of California San Francisco, San Francisco, California.
[5]
Prostate Cancer Clinical Trials Consortium, New York, New York.
[6]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
[7]
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
[8]
Bayer Oncology, Whippany, New Jersey.
[9]
Movember Foundation, East Melbourne, Australia.
[10]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[11]
Department of Oncology, Wayne State University Karmanos Cancer Institute, Detroit, Michigan.
[12]
Duke Cancer Institute, Durham, North Carolina.
[13]
DOI
10.1158/1055-9965.EPI-19-1616
PMID
32503813
发布时间
2023-11-11
换一批
换一批
